Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options
Publication
, Journal Article
Reichman, J
Published in: Journal of Law Medicine & Ethics
2009
Duke Scholars
Published In
Journal of Law Medicine & Ethics
Publication Date
2009
Volume
37
Start / End Page
247 / 263
Related Subject Headings
- Patents as Topic
- Mandatory Programs
- International Cooperation
- Humans
- Health Services Accessibility
- Drug and Narcotic Control
- Drug Industry
- Drug Discovery
- Drug Costs
- Diffusion of Innovation
Citation
APA
Chicago
ICMJE
MLA
NLM
Reichman, J. (2009). Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options. Journal of Law Medicine & Ethics, 37, 247–263.
Reichman, J. “Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options.” Journal of Law Medicine & Ethics 37 (2009): 247–63.
Reichman J. Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options. Journal of Law Medicine & Ethics. 2009;37:247–63.
Reichman, J. “Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options.” Journal of Law Medicine & Ethics, vol. 37, 2009, pp. 247–63.
Reichman J. Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options. Journal of Law Medicine & Ethics. 2009;37:247–263.
Published In
Journal of Law Medicine & Ethics
Publication Date
2009
Volume
37
Start / End Page
247 / 263
Related Subject Headings
- Patents as Topic
- Mandatory Programs
- International Cooperation
- Humans
- Health Services Accessibility
- Drug and Narcotic Control
- Drug Industry
- Drug Discovery
- Drug Costs
- Diffusion of Innovation